Sirtris Pharmaceuticals Report issue

For profit Phase 1 Phase 2
Founded: Cambrige MA United States (2004)
Status: Acquired by GlaxoSmithKline (2009)

Organization Overview

First Clinical Trial
2008
NCT00933530
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Sirtris, a GSK Company